Regencell bioscience holdings limited releases ceo letter to shareholders

Hong kong--(business wire)--regencell bioscience holdings limited (nasdaq: rgc) (“regencell” or the “company”), an early-stage bioscience company today released a letter from yat-gai au, founder and chief executive officer of the company. dear shareholders: as ceo of regencell, i am pleased to take this opportunity to discuss the significant milestones we achieved thus far in 2021, update our shareholders on our business plan for the remainder of the year and discuss our goals for 2022 and beyo
RGC Ratings Summary
RGC Quant Ranking